Qube Research & Technologies Ltd - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 283 filers reported holding INTELLIA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.81 and the average weighting 0.2%.

Quarter-by-quarter ownership
Qube Research & Technologies Ltd ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,431,090
-49.7%
45,259
-35.1%
0.00%
-60.0%
Q2 2023$2,843,997
+232.3%
69,740
+203.7%
0.01%
+150.0%
Q1 2023$855,943
-1.2%
22,966
-7.5%
0.00%
-20.0%
Q4 2022$866,493
-28.0%
24,835
+49.9%
0.01%
-50.0%
Q1 2022$1,204,000
+442.3%
16,572
+903.1%
0.01%
+233.3%
Q3 2021$222,000
-92.6%
1,652
-91.1%
0.00%
-91.2%
Q2 2021$3,009,00018,5840.03%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Atlas Venture Associates IX, LLC 1,113,376$89,359,00015.01%
Burrage Capital Management LLC 63,634$5,107,0004.14%
Integral Health Asset Management, LLC 170,000$13,643,0003.90%
Ally Bridge Group (NY) LLC 225,000$18,057,0003.46%
Elmwood Wealth Management, Inc. 67,174$5,391,0003.29%
Nikko Asset Management Americas, Inc. 4,843,270$388,697,0001.90%
ARK Investment Management 9,611,911$771,404,0001.53%
Spectrum Planning & Advisory Services Inc. 18,521$1,486,0001.53%
Lombard Odier Asset Management (Switzerland) SA 282,953$22,708,0001.51%
Intellectus Partners, LLC 71,625$4,606,0001.26%
View complete list of INTELLIA THERAPEUTICS INC shareholders